{
  "company": {
    "name": "GigaGen",
    "website": "https://gigagen.com/",
    "record": "https://startuphistory.org/c/gigagen.com"
  },
  "status": null,
  "history_since": "2011-01-28T19:44:50.000Z",
  "baseline": {
    "snapshot_id": "2308f095e1ec515b4ea6ced95da8068fca1372487834b58ec8910b9687f3d669",
    "observed_at": "2011-01-28T19:44:50.000Z",
    "headline": null,
    "description": "Massively parallel single cell genetic analysis",
    "evidence": "https://web.archive.org/web/20110128194450/http://gigagen.com/",
    "evidence_kind": "internet_archive",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [],
          "prices": [],
          "compliance": [],
          "funding": [
            "Recent Posts GigaGen secures seed funding GigaGen in China Collaboration with Dolomite Microfluidics Lab space at UCSF’s QB3 Incubator Network © 2011 GigaGen."
          ]
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 0,
  "last_checked": null,
  "live_status": "offline",
  "messaging": [
    {
      "quote_observed_at": "2014-09-18T03:11:43.000Z",
      "variants": [
        {
          "headline": "GigaGen | Technology and services for immunogenetics",
          "subhead": "Capture your immune-ome. GigaGen's Cell-Seq technology generates an immune molecular \"fingerprint\" for diagnostics in transplantation, autoimmunity, and cancer.",
          "observed_at": "2012-07-07T04:00:01.000Z",
          "evidence": "https://web.archive.org/web/20120707040001/http://gigagen.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "GigaGen | Technology and services for immunogenetics",
          "subhead": "Capture your immune-ome. GigaGen's Cell-Seq technology generates an immune molecular \"fingerprint\" for diagnostics in transplantation, autoimmunity, and cancer.",
          "observed_at": "2014-09-18T03:11:43.000Z",
          "evidence": "https://web.archive.org/web/20140918031143/http://gigagen.com:80/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "GigaGen | Technology and services for immunogenetics",
      "subhead": "Capture your immune-ome. GigaGen's Cell-Seq technology generates an immune molecular \"fingerprint\" for diagnostics in transplantation, autoimmunity, and cancer.",
      "from": "2012-07-07T04:00:01.000Z",
      "to": "2014-09-18T03:11:43.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20140918031143/http://gigagen.com:80/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2012-07-07T04:00:01.000Z",
          "to": "2014-09-18T03:11:43.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2016-01-09T18:23:56.000Z",
      "variants": [
        {
          "headline": "Technology for Therapeutic Natural Antibodies",
          "subhead": "GigaGen is a preclinical biopharmaceutical company with unique technology for capturing therapeutic natural antibodies from B cells.",
          "observed_at": "2016-01-09T18:23:56.000Z",
          "evidence": "https://web.archive.org/web/20160109182356/http://www.gigagen.com:80/?",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Technology for Therapeutic Natural Antibodies",
      "subhead": "GigaGen is a preclinical biopharmaceutical company with unique technology for capturing therapeutic natural antibodies from B cells.",
      "from": "2016-01-09T18:23:56.000Z",
      "to": "2016-01-09T18:23:56.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20160109182356/http://www.gigagen.com:80/?",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2016-01-09T18:23:56.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2019-07-20T18:35:35.000Z",
      "variants": [
        {
          "headline": "Overcoming Immune Dysregulation to Fight Disease",
          "subhead": "GigaGen’s proprietary approach delivers unprecedented insights into immune regulatory pathways and what causes them to fail, enabling a pipeline of novel antibody therapies for patients with cancer an",
          "observed_at": "2018-01-01T12:42:51.000Z",
          "evidence": "https://web.archive.org/web/20180101124251/http://gigagen.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Overcoming Immune Dysregulation to Fight Disease",
          "subhead": "GigaGen’s proprietary approach delivers unprecedented insights into immune regulatory pathways and what causes them to fail, enabling a pipeline of novel antibody therapies for patients with cancer an",
          "observed_at": "2019-07-20T18:35:35.000Z",
          "evidence": "https://web.archive.org/web/20190720183535/https://www.gigagen.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Overcoming Immune Dysregulation to Fight Disease",
      "subhead": "GigaGen’s proprietary approach delivers unprecedented insights into immune regulatory pathways and what causes them to fail, enabling a pipeline of novel antibody therapies for patients with cancer an",
      "from": "2018-01-01T12:42:51.000Z",
      "to": "2019-07-20T18:35:35.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20190720183535/https://www.gigagen.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2018-01-01T12:42:51.000Z",
          "to": "2019-07-20T18:35:35.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-10-03T20:53:13.000Z",
      "variants": [
        {
          "headline": "Advancing the Next Generation of Antibody Drugs",
          "subhead": "Our technology at GigaGen uniquely captures and recreates complete immune repertoires as functional antibody libraries to revolutionize antibody drug discovery and development.",
          "observed_at": "2021-07-09T22:09:16.000Z",
          "evidence": "https://web.archive.org/web/20210709220916/https://www.gigagen.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Advancing the Next Generation of Antibody Drugs",
          "subhead": "Our technology at GigaGen uniquely captures and recreates complete immune repertoires as functional antibody libraries to revolutionize antibody drug discovery and development.",
          "observed_at": "2023-02-07T20:19:22.000Z",
          "evidence": "https://web.archive.org/web/20230207201922/https://www.gigagen.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Advancing the Next Generation of Antibody Drugs",
          "subhead": "Our technology at GigaGen uniquely captures and recreates complete immune repertoires as functional antibody libraries to revolutionize antibody drug discovery and development.",
          "observed_at": "2025-01-01T04:57:05.000Z",
          "evidence": "https://web.archive.org/web/20250101045705/https://www.gigagen.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Advancing the Next Generation of Antibody Drugs",
          "subhead": "Our technology at GigaGen uniquely captures and recreates complete immune repertoires as functional antibody libraries to revolutionize antibody drug discovery and development.",
          "observed_at": "2026-10-03T20:53:13.000Z",
          "evidence": "https://web.archive.org/web/20261003205313/https://www.gigagen.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Advancing the Next Generation of Antibody Drugs",
      "subhead": "Our technology at GigaGen uniquely captures and recreates complete immune repertoires as functional antibody libraries to revolutionize antibody drug discovery and development.",
      "from": "2021-07-09T22:09:16.000Z",
      "to": "2026-10-03T20:53:13.000Z",
      "captures": 4,
      "evidence": "https://web.archive.org/web/20261003205313/https://www.gigagen.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-07-09T22:09:16.000Z",
          "to": "2026-10-03T20:53:13.000Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-2308f095e1ec515b4ea6ced95da8068fca1372487834b58ec8910b9687f3d669:239b7c27784a727516bf17924b9b984c40db3e2a1d385ceee1e1ff764fa69362:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20110128194450/http://gigagen.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2011-01-28T19:44:50.000Z",
        "to": "2012-07-07T04:00:01.000Z"
      },
      "evidence": "https://web.archive.org/web/20120707040001/http://gigagen.com:80/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 2,
      "id": "page-da4785e94fc9c4142dc467b0744329bfb935b7f303921c83328b3a0ea2ea4d1e:53b2a363ce4748e80d20ed23cdfa9019df5ba31786ae933e1f5066413b656edb:headline:934c533c30dfc380",
      "before_evidence": "https://web.archive.org/web/20140918031143/http://gigagen.com:80/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “GigaGen | Technology and services for immunogenetics” to “Technology for Therapeutic Natural Antibodies”.",
      "between": {
        "from": "2014-09-18T03:11:43.000Z",
        "to": "2016-01-09T18:23:56.000Z"
      },
      "evidence": "https://web.archive.org/web/20160109182356/http://www.gigagen.com:80/?",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 3,
      "id": "page-5da2f2d9c399b0e94feefaf1ea54152e23dd7ffa561ef5e3d6e2658539eaab86:31fad58f4d0147bbc4e898e9e554532b2cd6290318bc9af6e2863766360174e0:headline:d35fb6b46a7778d6",
      "before_evidence": "https://web.archive.org/web/20190720183535/https://www.gigagen.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Overcoming Immune Dysregulation to Fight Disease” to “Advancing the Next Generation of Antibody Drugs”.",
      "between": {
        "from": "2019-07-20T18:35:35.000Z",
        "to": "2021-07-09T22:09:16.000Z"
      },
      "evidence": "https://web.archive.org/web/20210709220916/https://www.gigagen.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “GigaGen” company record, https://startuphistory.org/c/gigagen.com"
}